586 related articles for article (PubMed ID: 25524484)
1. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
[TBL] [Abstract][Full Text] [Related]
2. The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population.
Shen XD; Wang X; Zheng ZJ; Chen YH; Tan CL; Liu XB; Ke NW
Cancer Med; 2023 May; 12(9):10438-10448. PubMed ID: 36938648
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
[TBL] [Abstract][Full Text] [Related]
4. Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.
Kays JK; Shahda S; Stanley M; Bell TM; O'Neill BH; Kohli MD; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):673-684. PubMed ID: 29978562
[TBL] [Abstract][Full Text] [Related]
5. Nutritional and immune impairments and their effects on outcomes in early pancreatic cancer patients undergoing pancreatoduodenectomy.
Tumas J; Tumiene B; Jurkeviciene J; Jasiunas E; Sileikis A
Clin Nutr; 2020 Nov; 39(11):3385-3394. PubMed ID: 32184025
[TBL] [Abstract][Full Text] [Related]
6. Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma.
Mitsunaga S; Kasamatsu E; Machii K
Support Care Cancer; 2020 Nov; 28(11):5271-5279. PubMed ID: 32103356
[TBL] [Abstract][Full Text] [Related]
7. Differentiating Sarcopenia and Cachexia Among Patients With Cancer.
Peterson SJ; Mozer M
Nutr Clin Pract; 2017 Feb; 32(1):30-39. PubMed ID: 28124947
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis.
Mintziras I; Miligkos M; Wächter S; Manoharan J; Maurer E; Bartsch DK
Int J Surg; 2018 Nov; 59():19-26. PubMed ID: 30266663
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer: let us focus on cachexia, not just sarcopenia!
Barreto SG
Future Oncol; 2018 Nov; 14(27):2791-2794. PubMed ID: 30192167
[No Abstract] [Full Text] [Related]
10. CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
Khristenko E; Sinitsyn V; Rieden T; Girod P; Kauczor HU; Mayer P; Klauss M; Lyadov V
PLoS One; 2024; 19(1):e0291185. PubMed ID: 38271373
[TBL] [Abstract][Full Text] [Related]
11. Cachexia worsens prognosis in patients with resectable pancreatic cancer.
Bachmann J; Heiligensetzer M; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
J Gastrointest Surg; 2008 Jul; 12(7):1193-201. PubMed ID: 18347879
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients.
Gingrich A; Volkert D; Kiesswetter E; Thomanek M; Bach S; Sieber CC; Zopf Y
BMC Geriatr; 2019 Apr; 19(1):120. PubMed ID: 31029082
[TBL] [Abstract][Full Text] [Related]
13. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.
Bachmann J; Ketterer K; Marsch C; Fechtner K; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
BMC Cancer; 2009 Jul; 9():255. PubMed ID: 19635171
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of weight loss, malnutrition and sarcopenia: A transatlantic view.
Schneider SM; Correia MITD
Nutrition; 2020 Jan; 69():110581. PubMed ID: 31622908
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later.
Ryan AM; Power DG; Daly L; Cushen SJ; Ní Bhuachalla Ē; Prado CM
Proc Nutr Soc; 2016 May; 75(2):199-211. PubMed ID: 26786393
[TBL] [Abstract][Full Text] [Related]
18. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
Biolo G; Cederholm T; Muscaritoli M
Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
[TBL] [Abstract][Full Text] [Related]
20. Measuring cachexia-diagnostic criteria.
Dev R
Ann Palliat Med; 2019 Jan; 8(1):24-32. PubMed ID: 30525765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
